CABTREO

Growth

clindamycin phosphate/benzoyl peroxide/adapalene

NDATOPICALGEL
Approved
Oct 2023
Lifecycle
Growth
Competitive Pressure
0/100

Mechanism of Action

Clindamycin: Clindamycin is a lincosamide antibacterial [see Microbiology ( )] . Adapalene: Adapalene binds to specific retinoic acid nuclear receptors but does not bind to cytosolic receptor protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of…

Pharmacologic Class:

Retinoid

Loss of Exclusivity

LOE Date
Dec 28, 2040
180 months away
Patent Expiry
Dec 28, 2040
Exclusivity Expiry
Oct 20, 2026

Patent Records (5)

Patent #ExpiryTypeUse Code
10220049
Jun 3, 2029
Product
U-3713
10624918
Jun 3, 2029
U-3713
9561208
Jun 3, 2029
Product
U-3713
8288434
Aug 5, 2029
Product
U-3713
12128059
Jul 31, 2040
Product
U-3713